Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity

Conclusion: One injection of 0.3 mg intravitreal ranibizumab is effective in treating ROP stage III mainly in zones I and II.Med Princ Pract
Source: Medical Principles and Practice - Category: Internal Medicine Source Type: research